Atlas Trials

Phase I-II Vaccination of Autologous Dendritic Cells Transduced With Adenoviral Vector Encoding NS3 in Hepatitis C Encoding NS3 in Hepatitis C

Clinical trial NCT02309086 · TERMINATED

Trial details

NCT number
NCT02309086
Sponsor
Clinica Universidad de Navarra, Universidad de Navarra
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Hepatitis C, Chronic
Start date
2011-05-01
Primary completion
2013-05-01
Enrollment
5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.